Cardiovascular disease affects nearly half of the adults in the United States, posing a significant public health challenge.
Takeda pulls dengue vaccine application after FDA requests more data
Takeda has withdrawn an FDA application for its dengue vaccine candidate following a request by regulators for more data. The Japanese biotech filed a biologics